-
Study aim
-
Determining the prophylactic effect of neostigmine and atropine combination on the occurrence of post-dural puncture headache in patients undergoing spinal anesthesia with a control group
-
Design
-
A randomized double-blinding clinical trial, with the parallel groups
-
Settings and conduct
-
In this study, 100 patients will be included as candidates for lower extremity and lower abdomen surgery and will be randomly divided into two groups. Neostigmine and atropine will be used in one group and normal saline in the other. Then the severity of patients' headaches is evaluated.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria are patient consent to participate in the study, American Society of Anesthesiologists classification of I and II, and surgery duration less than 2 hours. Exclusion criteria include taking anticoagulants, presence of nerve damage in limbs and spine, coagulation diseases, history of spinal surgery, spinal canal stenosis and MS, conduction disorders of the heart, history of migraine headaches, addiction to drugs, and a history of malignancy.
-
Intervention groups
-
In this study, all patients will undergo spinal block. After performing spinal block and confirming its accuracy, patients in the intervention group will be prescribed a combination of 400 g of neostigmine and 200 g of atropine and in the control group normal saline. Thus, for every 10 kg of patient weight, 1 cc is administered intravenously.
-
Main outcome variables
-
Severity of headache, duration of headache